Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)

PHASE3CompletedINTERVENTIONAL

Enrollment

346

Participants

Timeline

Start Date

December 7, 2006

Primary Completion Date

August 17, 2009

Study Completion Date

August 17, 2009

Conditions

Insomnia

Interventions

DRUG

Org 50081

One tablet daily

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00610675 - Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708) | Biotech Hunter | Biotech Hunter